As announced on 25 June 2018, MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) entered into a binding share sale agreement pursuant to which it conditionally agreed to sell its wholly-owned subsidiary PhytoTech Therapeutics Ltd to Harvest One Cannabis Inc. (CVE:HVT) for total consideration of CAD$8 million.
Oventus Medical Ltd (ASX:OVN) provides the Company's 2018 AGM Presentation.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) advises that its wholly owned subsidiary, Vertical Canna Inc has entered into a binding agreement to conduct due diligence for the acquisition of a Canadian company which is in final stages of becoming a Licenced Producer of Cannabis.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) announcing that it has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc (CVE:FIRE).
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached news release by Harvest One Cannabis Inc. (CVE:HVT) announcing that it has entered into a multi-year cannabis extraction services agreement with Valens GroWorks Corp. (CNSX:VGW).
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) confirming that it has been issued a sales licence by Health Canada.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce that it has invested CAD$2.5 million of equity into privately-held Embark Health Inc. This increases MMJ's total investment in Embark to CAD$2.65 million for a basic shareholding of circa 10%*.
